Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Annals of the Rheumatic Diseases
|
December 21, 2012
Recent progress in conventional and biologic therapy for systemic lupus erythematosus
David Wofsy
Nature Reviews. Rheumatology
|
June 4, 2009
Systemic lupus erythematosus clinical trials-an interim analysis
Maria Dall'Era, David Wofsy
Current Opinion in Rheumatology
|
August 10, 2006
Clinical trial design in systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Discovery Medicine
|
January 28, 2010
Biologic therapy for systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Arthritis and Rheumatism
|
March 27, 2013
Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials
David Wofsy, Jan L Hillson, Betty Diamond
Arthritis and Rheumatism
|
July 19, 2012
Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions
David Wofsy, Jan L Hillson, Betty Diamond
Nature Reviews. Rheumatology
|
October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritis
Jonathan H Esensten, David Wofsy, Jeffrey A Bluestone
Nature Reviews. Nephrology
|
December 20, 2019
Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis
Deepak A Rao, Arnon Arazi, David Wofsy, et al.
Lupus Science & Medicine
|
May 30, 2015
Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
Maria Dall'Era, Victoria Levesque, Neil Solomons, et al.
Arthritis Care & Research
|
November 17, 2010
Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide
Maria Dall'Era, David Stone, Victoria Levesque, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Annals of the Rheumatic Diseases
|
December 21, 2012
Recent progress in conventional and biologic therapy for systemic lupus erythematosus
David Wofsy
Nature Reviews. Rheumatology
|
June 4, 2009
Systemic lupus erythematosus clinical trials-an interim analysis
Maria Dall'Era, David Wofsy
Current Opinion in Rheumatology
|
August 10, 2006
Clinical trial design in systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Discovery Medicine
|
January 28, 2010
Biologic therapy for systemic lupus erythematosus
Maria Dall'Era, David Wofsy
Arthritis and Rheumatism
|
March 27, 2013
Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials
David Wofsy, Jan L Hillson, Betty Diamond
Arthritis and Rheumatism
|
July 19, 2012
Abatacept for lupus nephritis: alternative definitions of complete response support conflicting conclusions
David Wofsy, Jan L Hillson, Betty Diamond
Nature Reviews. Rheumatology
|
October 3, 2009
Regulatory T cells as therapeutic targets in rheumatoid arthritis
Jonathan H Esensten, David Wofsy, Jeffrey A Bluestone
Nature Reviews. Nephrology
|
December 20, 2019
Design and application of single-cell RNA sequencing to study kidney immune cells in lupus nephritis
Deepak A Rao, Arnon Arazi, David Wofsy, et al.
Lupus Science & Medicine
|
May 30, 2015
Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome
Maria Dall'Era, Victoria Levesque, Neil Solomons, et al.
Arthritis Care & Research
|
November 17, 2010
Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide
Maria Dall'Era, David Stone, Victoria Levesque, et al.
Page
of 6